Hepatic lipase gene polymorphism, pre-pregnancy overweight status and risk of preeclampsia among Peruvian women

References

• Roberts J M, Pearson G, Cutler J, Lindheimer M. Summary of the NHLBI Working Group on Research on Hypertension During Pregnancy. Hypertension 2003; 41: 437–445
   PubMed Web of Science ®Google Scholar
• Dekker G A, Sibai B M. Etiology and pathogenesis of preeclampsia: current concepts. Am J Obstet Gynecol 1998; 179: 1359–1375
   PubMed Web of Science ®Google Scholar
• Wilson M L, Goodwin T M, Pan V L, Ingles S A. Molecular epidemiology of preeclampsia. Obstet Gynecol Surv 2003; 58: 39–66
   PubMed Web of Science ®Google Scholar
• Lachmeijer A M, Dekker G A, Pals G, Aarnoudse J G, ten Kate L P, Arngrimsson R. Searching for preeclampsia genes: the current position. Eur J Obstet Gynecol Reprod Biol 2002; 105: 94–113
   PubMed Web of Science ®Google Scholar
• Lorentzen B H. Plasma lipids and vascular dysfunction in preeclampsia. Sem in Reproductive Endocrinology 1998; 16: 33–39
   PubMedGoogle Scholar
• Enquobahrie D A, Williams M A, Butler C L, Frederick I O, Miller R S, Luthy D A. Maternal plasma lipid concentrations in early pregnancy and risk of preeclampsia. Am J Hypertens 2004; 17: 574–581
   PubMed Web of Science ®Google Scholar
• Ware-Jauregui S, Sanchez S E, Zhang C, Laraburre G, King I B, Williams M A. Plasma lipid concentrations in pre-elcamptic and normotensive Peruvian women. Int J Gynaecol Obstet 1999; 67: 147–155
   PubMed Web of Science ®Google Scholar
• Sparkes R S, Zollman S, Klisak I, Kuchgessner T G, Komaromy M C, Mohandas T, Schotz M C, Lusis A J. Human genes involved in lipolysis of plasma lipoproteins; mapping of loci for lipoprotein lipase to 8p22 and hepatic lipase to 15q21. Genomics 1987; 1: 138–144
   PubMedGoogle Scholar
• Ameis D, Stahnke G, Kobayashi J, McLean J, Lee G, Buscher M, Schotz M C, Will H. Isolation and characterization of the human hepatic lipase gene. J Biol Chem 1990; 265: 6552–6555
   PubMedGoogle Scholar
• Cai S J, Wong D M, Chen S H, Chan L. Structure of the human hepatic triglyceride lipase gene. Biochemistry 1989; 28: 8966–8971
   PubMed Web of Science ®Google Scholar
• Jansen H, Verhoeven A J, Sijbrands E J. Hepatic lipase: a pro- or anti-atherogenic protein?. J Lipid Res 2002; 43: 1352–1362
   PubMed Web of Science ®Google Scholar
• Rizzo M, Taylor J M, Barbagallo C M, Berneis K, Blanche P J, Krauss R M. Effects on lipoprotein subclasses of combined expression of human hepatic lipase and human apoB in transgenic rabbits. Arterioscler Thromb Vasc Biol 2004; 24: 141–146
   PubMed Web of Science ®Google Scholar
• Andersen R V, Wittrup H H, Tybjaerg-Hansen A, Steffensen R, Schnohr P, Nordestgaard B G. Hepatic lipase mutations, elevated high-density lipoprotein cholesterol, and increased risk of ischemic heart disease: the Copenhagen City Heart Study. J Am Coll Cardiol 2003; 41: 1972–1982
   PubMedGoogle Scholar
• Juo S H, Han Z, Smith J D, Colangelo L, Liu K. Promoter polymorphisms of hepatic lipase gene influence HDL(2) but not HDL(3) in African American men: CARDIA study. J Lipid Res 2001; 42: 258–264
   PubMedGoogle Scholar
• Guerra R, Wang J, Grundy S M, Cohen J C. A hepatic lipase (LIPC) allele associated with high plasma concentrations of high density lipoprotein cholesterol. Proc Natl Acad Sci U S A 1997; 94: 4532–4537
   PubMed Web of Science ®Google Scholar
• van't Hooft F M, Lundahl B, Ragogna F, Karpe F, Olivecrona G, Hamsten A. Functional characterization of 4 polymorphisms in promoter region of hepatic lipase gene. Arterioscler Thromb Vasc Biol 2000; 20: 1335–1339
   PubMedGoogle Scholar
• Zambon A, Deeb S S, Pauletto P, Crepaldi G, Brunzell J D. Hepatic lipase: a marker for cardiovascular disease risk and response to therapy. Curr Opin Lipidol 2003; 14: 179–189
   PubMedGoogle Scholar
• Tahvanainen E, Syvanne M, Frick H M, Murtomaki-Repo S, Antikainen M, Kesaniemi A, Kauma H, Pasternak A, Taskinen M, Ehnholm C. Association of variation in hepatic lipase activity with promoter variation in the hepatic lipase gene. J Clin Invest 1998; 101: 956–960
   PubMedGoogle Scholar
• Pihlajamaki J, Karjalainen L, Karhapaa P, Vauhkonen I, Taskinen M R, Deeb S S, Laakso M. G-250A substitution in promoter of hepatic lipase gene is associated with dyslipidemia and insulin resistance in healthy control subjects and in members of families with familial combined hyperlipidemia. Arterioscler Thromb Vasc Biol 2000; 20: 1789–1795
   PubMedGoogle Scholar
• Su Z, Zhang S, Nebert D W, Zhang L, Huang D, Hou Y, Liao L, Xiao C. A novel allele in the promoter of the hepatic lipase is associated with increased concentration of HDL-C and decreased promoter activity. J Lipid Res 2002; 43: 1595–1601
   PubMed Web of Science ®Google Scholar
• Hegele R A, Harris S, Brunt J H, Young T K, Hanley A J, Zinman B, Connelly P W. Absence of association between genetic variation in the LIPC gene promoter and plasma lipoproteins in three Canadian populations. Atherosclerosis 1999; 146: 153–160
   PubMed Web of Science ®Google Scholar
• Connelly P W, Hegele R A. Hepatic lipase deficiency. Crit Rev Clin Lab Sci 1998; 35: 547–572
   PubMed Web of Science ®Google Scholar
• Deeb S S, Zambon A, Carr M C, Ayyobi A F, Brunzell J D. Hepatic lipase and dyslipidemia: interactions among genetic variants, obesity, gender, and diet. J Lipid Res 2003; 44: 1279–1286
   PubMedGoogle Scholar
• Nie L, Wang J, Clark L T, Tang A, Vega G L, Grundy S M, Cohen J C. Body mass index and hepatic lipase gene (LIPC) polymorphism jointly influence postheparin plasma hepatic lipase activity. J Lipid Res 1998; 39: 1127–1130
   PubMed Web of Science ®Google Scholar
• Muy-Rivera M, Sanchez S E, Vadachkoria S, Qiu C, Bazul V, Williams M A. Transforming growth factor-beta1 (TGF-beta1) in plasma is associated with preeclampsia risk in Peruvian women with systemic inflammation. Am J Hypertens 2004; 17: 334–338
   PubMed Web of Science ®Google Scholar
• American College of Obstetricians and Gynecologists. Hypertension in pregnancy. ACOG Technical Bulletin 1996; 219: 1–8
   Google Scholar
• Somekawa Y, Umeki H, Kobayashi K, Tomura S, Aso T, Hamaguchi H. Effects of hormone replacement therapy and hepatic lipase polymorphism on serum lipid profiles in postmenopausal Japanese women. J Clin Endocrino Metab 2002; 87: 4766–4770
   PubMedGoogle Scholar
• Hokanson J E, Kamboh M I, Scarboro S, Eckel R H, Hamman R F. Effects of Hepatic Lipase Gene and Physical Activity on Coronary Heart Disease Risk. Am J Epidemiol 2003; 158: 836–843
   PubMedGoogle Scholar
• Rothman K J, Greenland S. Modern Epidemiology. 2nd ed. Lippincott-Raven Publishers, Philadelphia 1998; 253–258
   Google Scholar
• National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol 2000; 183: S1–S22
   PubMed Web of Science ®Google Scholar
• Couture P, Otvos J D, Cupples L A, Lahoz C, Wilson P WF, Schaefer E J, Ordovas J M. Association of the C−514T polymorphism in the hepatic lipase gene with variations in lipoprotein subclass profiles. Arterioscler Thromb 2000; 20: 815–822
   PubMedGoogle Scholar
• Jansen H, Waterworth D M, Nicaud V, Ehnholm C, Talmud P J. Interaction of the common apolipoprotein C-III (APOC3 −482C>T) and hepatic lipase (LIPC −514C>T) promoter variants affects glucose tolerance in young adult. European Atherosclerosis Research Study II (EARS-II). Ann Hum Genet 2001; 65: 237–243
   PubMedGoogle Scholar
• Clay M A, Newnham H H, Forte T M, Barter P I. Cholesteryl ester transfer protein and hepatic lipase activity promote shedding of apo A-I from HDL and subsequent formation of discoidal HDL. Biochim Biophys Acta 1992; 1124: 52–58
   PubMed Web of Science ®Google Scholar
• Carr M C, Hokanson J E, Deeb S S, Purnell J Q, Mitchell E S, Brunzell J D. A hepatic lipase gene promoter polymorphism attenuates the increase in hepatic lipase activity with increasing intra-abdominal fat in women. Arterioscler Thromb Vasc Biol 1999; 19: 2701–2707
   PubMedGoogle Scholar
• Seely E W, Solomon C G. Insulin resistance and its potential role in pregnancy-induced hypertension. J Clin Endocrinol Metab 2003; 88: 2393–2398
   PubMed Web of Science ®Google Scholar
• Reaven G M. Pathophysiology of insulin resistance in human disease. Physiol Rev 1995; 75: 473–486
   PubMed Web of Science ®Google Scholar
• Cales-Escandon J, Cipolla M. Diabetes and endothelial dysfunction: a clinical perspective. Endocr Rev 2001; 22: 36–52
   PubMedGoogle Scholar
• Cominacini L, Garbin U, Davoli A, Campagnola M, De Santis A, Pasini C, Pastorino A M, Bosello O. High-denisity lipoprotein cholesterol concentrations and postheparin hepatic and lipoprotein lipases in obesity: relationships with plasma insulin levels. Ann Nutr Metab 1993; 37: 175–184
   PubMedGoogle Scholar
• Simonen P P, Gylling H, Miettinen T A. Body weight modulates cholesterol metabolism in Non-insulin dependent type 2 diabetics. Obes Res 2002; 10: 328–335
   PubMedGoogle Scholar